EICHOR
● Recruiting
A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
Condition: Colitis, Ulcerative · Sponsor: Xian-Janssen Pharmaceutical Ltd.
About this study
The purpose of this study is to assess the measurable changes in health, function, or quality of life (clinical outcomes) after receiving guselkumab in real-world clinical practice amongst Chinese participants with ulcerative colitis (UC; a long-term disease of the large intestine in which the lining of the colon \[part of large intestine\] becomes inflamed and develops tiny open ulcers), who have not received biologic therapy (a medicine made from living organisms or their components) previously.
This description comes directly from the study's public registry record.
Talk to the study team
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
Locations (10)
| Peking Union Medical College Hospital | Beijing, China | Recruiting |
| Peking University People's Hospital | Beijing, China | Recruiting |
| Changzhou No 2 Peoples Hospital | Changzhou, China | Recruiting |
| The First Affiliated Hospital Sun Yat-Sen University | Guangzhou, China | Recruiting |
| The Sixth Affiliated Hospital of Sun Yat-sen University | Guangzhou, China | Recruiting |
| The Second Affiliated Hospital of Zhejiang University | Hangzhou, China | Recruiting |
| Sir Run Run Shaw Hospital Zhejiang University School of Medicine | Hangzhou, China | Recruiting |
| Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School | Nanjing, China | Recruiting |
| The Second Hospital of Hebei Medical University | Shijiazhuang, China | Recruiting |
| Tianjin Medical University General Hospital | Tianjin, China | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07302360